ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 219 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $25,000 | +177.8% | 265 | +72.1% | 0.00% | – |
Q3 2021 | $9,000 | +12.5% | 154 | +31.6% | 0.00% | – |
Q2 2021 | $8,000 | -63.6% | 117 | -63.7% | 0.00% | – |
Q1 2021 | $22,000 | +15.8% | 322 | +27.3% | 0.00% | – |
Q4 2020 | $19,000 | +90.0% | 253 | +97.7% | 0.00% | – |
Q3 2020 | $10,000 | 0.0% | 128 | -16.3% | 0.00% | – |
Q2 2020 | $10,000 | +400.0% | 153 | +212.2% | 0.00% | – |
Q1 2020 | $2,000 | 0.0% | 49 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | -80.0% | 49 | -77.1% | 0.00% | – |
Q3 2019 | $10,000 | +900.0% | 214 | +791.7% | 0.00% | – |
Q2 2019 | $1,000 | 0.0% | 24 | 0.0% | 0.00% | – |
Q1 2019 | $1,000 | 0.0% | 24 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | 0.0% | 24 | 0.0% | 0.00% | – |
Q3 2018 | $1,000 | 0.0% | 24 | 0.0% | 0.00% | – |
Q2 2018 | $1,000 | -92.9% | 24 | -93.1% | 0.00% | – |
Q1 2018 | $14,000 | -6.7% | 349 | -19.8% | 0.00% | – |
Q4 2017 | $15,000 | -40.0% | 435 | -56.8% | 0.00% | – |
Q3 2017 | $25,000 | – | 1,006 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |